Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 360 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Polyzos, Stergios A [Clear All Filters]
Farnesoid X nuclear receptor agonists for the treatment of nonalcoholic steatohepatitis..
Eur J Pharmacol. 863, 172661.
(2019). Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement..
Metabolism. 96, 66-82.
(2019). Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy Controls..
Horm Metab Res. 51(2), 112-119.
(2019). Gastroesophageal reflux disease, irritable bowel syndrome and functional dyspepsia as overlapping conditions: focus on effect of trimebutine..
Ann Gastroenterol. 32(3), 318.
(2019). Helicobacter pylori infection and gastrointestinal tract cancer biology: considering a double-edged sword reflection..
Cell Mol Life Sci. 76(13), 2487-2488.
(2019). Helicobacter pylori infection and nonalcoholic fatty liver disease: Time for large clinical trials evaluating eradication therapy..
Helicobacter. 24(3), e12588.
(2019). Helicobacter pylori infection and nonalcoholic fatty liver disease: Are the four meta-analyses favoring an intriguing association pointing to the right direction?.
Metabolism. 96, iii-v.
(2019). Helicobacter pylori Infection: One More Contributor to Nonalcoholic Fatty Liver Disease Pathophysiology..
J Clin Gastroenterol.
(2019). Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on incidence of all-cause and Alzheimer's dementia..
Alzheimers Dement. 15(5), 723-725.
(2019). Impact of nitric oxide's bidirectional role on glaucoma: focus on Helicobacter pylori-related nitrosative stress..
Ann N Y Acad Sci.
(2019). Impact of occupational stress on irritable bowel syndrome pathophysiology and potential management in active duty noncombat Greek military personnel: a multicenter prospective survey..
Eur J Gastroenterol Hepatol.
(2019).
(2019). Irisin: good or bad for the bone? A new path forward after the reported discovery of irisin receptor?.
Metabolism. 93, 100-102.
(2019). Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives..
Curr Vasc Pharmacol. 17(6), 546-555.
(2019). Metabolic syndrome components including high abdominal obesity and sarcopenia in patients with inflammatory bowel disease..
Ann Gastroenterol. 32(2), 214.
(2019).
(2019).
(2019). Non-alcoholic fatty liver disease treatment in patients with type 2 diabetes mellitus; new kids on the block..
Curr Vasc Pharmacol.
(2019). Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: a proof of concept study..
Metabolism. 154005.
(2019). Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort..
Horm Metab Res. 51(2), 134-140.
(2019). Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics..
Metabolism. 92, 82-97.
(2019). Obesity: seize the day, fight the fat..
Metabolism. 92, 1-5.
(2019). Of mice and men: Why progress in the pharmacological management of obesity is slower than anticipated and what could be done about it?.
Metabolism. 96, vi-xi.
(2019). Off-label uses of denosumab in metabolic bone diseases..
Bone. 129, 115048.
(2019). A perspective on risk factors for esophageal adenocarcinoma: emphasis on Helicobacter pylori infection..
Ann N Y Acad Sci. 1452(1), 12-17.
(2019).